Antipsoriatic Drug Development: Challenges and New Emerging Therapies

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|6|1|3-21

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.6, Iss.1, 2012-01, pp. : 3-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspectives of New Therapies for Endometriosis

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 3, 2012-09 ,pp. : 218-223

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapies in SLE

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 1, 2008-01 ,pp. : 11-23

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Therapies for Dyslipidemia: Known Knowns and Known Unknowns of MTP Inhibitors

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 24-29

Bentham Science Publishers

Access to resources Recommend Favorite

Liposomal Drug Delivery: Recent Patents and Emerging Opportunities

By  

Recent Patents on Drug Delivery & Formulation, Vol. 1, Iss. 3, 2007-11 ,pp. : 185-194

Bentham Science Publishers

Access to resources Recommend Favorite

Medullary Thyroid Cancer: New Targeted Molecular Therapies

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 1, 2010-01 ,pp. : 10-14

Bentham Science Publishers

Access to resources Recommend Favorite